Bud Glogovac is an accomplished finance professional with extensive experience in leadership roles across notable organizations. Currently serving as Finance Director (Country CFO) at Bristol-Myers Squibb since June 2015, Bud has successfully navigated significant industry changes while exceeding financial targets and implementing effective organizational initiatives. Prior to this, Bud held finance director positions at GlaxoSmithKline and GMS Pharmaceuticals, where responsibilities included rebuilding finance teams and improving operational performance. Bud's earlier experience at Toll Group involved leading business development and turning around the profitability of acquired entities. Bud is a Fellow of CPA Australia and holds a Bachelor of Business Administration in Accounting from Victoria University.